Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07350499 · ClinicalTrials.gov registry record
Aspiration Thrombectomy Using the Symphony or Prodigy System
A clinical trial of Pulmonary Embolism and Venous Thromboembolism, sponsored by Imperative Care.
- Recruiting
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT07350499: Recruiting study of Pulmonary Embolism and Venous Thromboembolism, sponsored by Imperative Care.
NCT07350499 is a study of Pulmonary Embolism and Venous Thromboembolism that is actively recruiting participants, run by Imperative Care. The registered enrollment target is 750 participants, below the 3,043-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07350499, a study of Pulmonary Embolism and Venous Thromboembolism, is actively recruiting participants, sponsored by Imperative Care.
- RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.
Primary Outcome
Freedom from major (above-ankle) unanticipated amputation of the index limb
Conditions Studied
Interventions
- DEVICE Prodigy Thrombectomy System
- DEVICE Symphony Thrombectomy System
Study Locations (1)
Alabama
- Huntsville Hospital - Huntsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2026-01-23 |
| Est. Completion | 2030-09 |
What NCT07350499 shows while recruiting
NCT07350499 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 3,043-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Prodigy Thrombectomy System is the first listed.
NCT07350499 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT07350499 about?
NCT07350499 is a clinical study titled "Aspiration Thrombectomy Using the Symphony or Prodigy System". The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.
What is the current status of trial NCT07350499?
This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2026-01-23. Estimated completion is 2030-09.
What conditions does trial NCT07350499 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Venous Thromboembolism, Arterial Thromboembolism.
What interventions are being tested in trial NCT07350499?
The interventions under investigation include: Prodigy Thrombectomy System (DEVICE), Symphony Thrombectomy System (DEVICE).
Who is sponsoring clinical trial NCT07350499?
This trial is sponsored by Imperative Care, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07350499 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07350499's enrollment target sits among peer trials
750 11th of 48 higher than 38 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
-
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI